Peptide family: Bivalirudin
A direct thrombin inhibitor used in anticoagulation therapy. It belongs to the family of peptide anticoagulants.
The USP biologics peptides category encompasses a diverse range of therapeutic peptides that are essential in managing various medical conditions. These peptides, typically consisting of amino acid sequences of 40 residues or less, are critical for the development of high-quality medicines. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of peptide therapeutics throughout their lifecycle.
The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.
| MDL number | MFCD01730597 |
|---|---|
| NACRES | NA.24 |
| UNSPSC Code | 41116107 |
| API family | bivalirudin |
| form | solid |
| packaging | pkg of 1 mg |
| manufacturer/tradename | USP |
| application(s) | USP Biologicspharmaceutical (small molecule) |
| format | neat |
| storage temp. | −20°C |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
